GENE ONLINE|News &
Antibody Drug Conjugates: The Next Big Thing in Cancer Therapy?
Cancer is the second most common cause of global deaths, accounting for approximately 10 million per year. It is estimated that in 2021 there will be an additional 1.9 million new cases in the US alone, with around 600,000 deaths. Cancer therapy has improved over the last decade, thanks to technological advances and research Progress. Here we take a closer look at one such significant advance, the antibody conjugated drugs (ADCs).
What are ADCs?
GO Prime with only $1.49 now
LATEST
Sanofi and Regeneron’s Dupixent Approved as First-in-World Treatment For Uncontrolled COPD
2024-07-04
FDA Greenlights Eli Lilly’s Groundbreaking Alzheimer’s Drug Kisunla for Early Symptomatic Treatment
2024-07-04
Novo Nordisk’s CLARION-CKD Trial Shut Down After Unsuccessful Results Causing Impairment Loss
2024-07-03
